Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Rev. Asoc. Odontol. Argent ; 98(3): 259-264, jun.-jul. 2010.
Article in Spanish | LILACS | ID: lil-594985

ABSTRACT

El incremento permanente a nivel mundial y en nuestro país del consumo de drogas ilegales y la posible asociación entre su consumo y el bruxismo son motivo de inquietud social y en particular de los odontólogos. En este estudio se presenta información actualizada de las distintas drogas de consumo habitual entre los adictos, los mecanismos bioquímicos generados a nivel orgánico en aquellos que las consumen y su posible asociación como factor causal de bruxismo.


Subject(s)
Humans , Bruxism , Illicit Drugs , Substance-Related Disorders , Alcoholism/complications , /adverse effects , Amphetamine-Related Disorders/complications
2.
Article in English | IMSEAR | ID: sea-43846

ABSTRACT

OBJECTIVES: To determine the perinatal impacts of heroin and amphetamine on both mothers and infants. MATERIAL AND METHOD: This is a retrospective study on the influence of amphetamine and heroin on pregnant women and their newborn infants at King Chulalongkorn Memorial Hospital in Bangkok, Thailand, between January 1997 and December 2002. The medical and demographic data of both mothers and infants were evaluated. Comparison of the consistent drug effects of these 2 drugs on the mothers and infants were also performed RESULTS: Two hundred and eleven women were identified There were 178 (84.4%) and 33 (15.6%) women addicted to amphetamine and heroin respectively. Sixty one (28.9%) of them were polydrug users. There were more polydrug users among heroin addicts than amphetamine addicts, (43.7% vs 27.2%, p < 0.05). Poor obstetric history were noted in both groups of women including lack of prenatal care (74.9%), a high incidence of previous abortion (22.3%), positive HIV serology test (11.1%), pre-eclampsia (5.2%), infection (3.3%) and antepartum hemorrhage (1.9%). Drug intoxication was found in 11 amphetamine addicted mothers, whereas 2 heroin addicts developed withdrawal symptoms during intrapartum and postpartum periods. All infants were singleton. There was one stillbirth and 2 neonatal deaths. There was no statistical difference in terms of sex ratio, mean birth weight, gestational age, length, head circumference and Apgar score between the groups of amphetamine and heroin exposed infants. The incidence of prematurity, low birth weight, IUGR and microcephaly were not statistically different between both groups of infants. The overall incidence was 31.7%, 31.7%, 9.5% and 8.6% respectively. Congenital anomalies were found in 5 (2.8%) amphetamine exposed infants. Thirty one out of 33 heroin exposed infants (93.9%) and 4 out of 178 amphetamine exposed infants (2.2%) developed drug withdrawal symptoms with the mean onset of 21.5 +/- 16.5 hours and 10.3 +/- 7.5 hours respectively, p > 0.05. All heroin withdrawal infants were successfully treated with Phenobarbital with the mean duration of treatment of 23.7 +/- 11.5 days. None of the amphetamine withdrawal infants needed specific treatment. They recovered spontaneously within 6.0 +/- 5.3 days. Eighteen infants were left in an orphanage or under the custody of their relatives. CONCLUSION: Amphetamine or heroin use during pregnancy can cause many serious adverse effects on both mothers and infants. The findings in the present study are consistent with previous reports, although they seemed to be more common and severe. Increasing awareness and improving understanding of drug abuse in the medical, legal and social aspects are needed in order to reduce these impacts.


Subject(s)
Abnormalities, Drug-Induced/epidemiology , Adult , Amphetamine-Related Disorders/complications , Female , Heroin Dependence/complications , Humans , Infant Welfare , Infant, Low Birth Weight , Infant, Newborn , Infant, Premature , Male , Maternal Welfare , Maternal-Fetal Exchange , Neonatal Abstinence Syndrome/epidemiology , Perinatal Care , Pregnancy , Pregnancy Complications/chemically induced , Pregnancy Outcome , Retrospective Studies , Risk Factors , Thailand/epidemiology
3.
Southeast Asian J Trop Med Public Health ; 2002 Dec; 33(4): 849-51
Article in English | IMSEAR | ID: sea-31128

ABSTRACT

Hepatitis C virus (HCV) is an infectious agent that has the potential to cause chronic liver disease, cirrhosis and hepatocellular carcinoma. We determined the prevalence and genotypes of HCV infection among groups of drug addicts: intravenous drug users (n = 134), methamphetamine users (n = 100), inhaled-drugs users (n = 19) and alcoholics (n = 50); a group of blood donors acted as a control. The control group consisted of 179 randomly-selected anti-HCV positive samples: these were subjected to HCV RNA screening and genotyping. The anti-HCV test was performed by ELISA: HCV RNA screening was by nested RT-PCR that employed primers from the 5' noncoding region. The genotype assay was based upon analysis of the 5' NCR amplified sequences and RFLP. Hepatitis C virus was highly prevalent among all groups of drug addicts (12-70%). In 2000. among the new blood donors (n = 66,340) at the National Blood Center, Thai Red Cross, anti-HCV prevalence amounted to 0.98%. The HCV genotype distribution showed that the most prevalent genotype was 3a, followed by 1b and 6a. Our data demonstrated the very high prevalence of HCV infection in IVDUs, a finding that is consistent with the blood-borne nature of the virus. In order to curb HCV infection, a determined effort to educate both the general population and high-risk groups is required; such a program of education would address both general and particular methods of transmission, especially the use of non-sterile needles etc.


Subject(s)
Alcoholism/complications , Amphetamine-Related Disorders/complications , Blood Donors/statistics & numerical data , Enzyme-Linked Immunosorbent Assay , Genotype , Health Education , Hepacivirus/classification , Hepatitis C/epidemiology , Humans , Mass Screening , Methamphetamine , Needle Sharing/statistics & numerical data , Needs Assessment , Population Surveillance , RNA, Viral/analysis , Reverse Transcriptase Polymerase Chain Reaction , Risk Factors , Seroepidemiologic Studies , Substance Abuse, Intravenous/complications , Thailand/epidemiology
4.
In. Timerman, Ari; Machado César, Luiz Antonio; Ferreira, Joäo Fernando Monteiro; Bertolami, Marcelo Chiara. Manual de Cardiologia: SOCESP. Säo Paulo, Atheneu, 2000. p.550-2, tab.
Monography in Portuguese | LILACS | ID: lil-265479
SELECTION OF CITATIONS
SEARCH DETAIL